686VPThorough QT study on the effect of therapeutic and supratherapeutic dosing of givinostat in healthy volunteersTracey Willis, S. Cazzaniga, E. Mercuri et al.|Neuromuscular Disorders|2025Cited by 0
679VPEfficacy of givinostat in the off-target population of EPIDYS: a subgroup analysisC. Laverty, Richard S. Finkel, P. Bettica et al.|Neuromuscular Disorders|2025Cited by 0